Cargando…
Network pharmacology analysis reveals potential targets and mechanisms of proton pump inhibitors in breast cancer with diabetes
Breast cancer and diabetes are significant health challenges, and effective treatments for both diseases are lacking. Proton pump inhibitors (PPIs) have demonstrated anticancer and hypoglycemic effects, but their mechanisms of action are not yet fully understood. We used the GeneCards and PharmMappe...
Autores principales: | Hu, Haihong, Wang, Hanbin, Yang, Xiaoyan, Li, Zhicheng, Zhan, Wendi, Zhu, HongXia, Zhang, Taolan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172348/ https://www.ncbi.nlm.nih.gov/pubmed/37165049 http://dx.doi.org/10.1038/s41598-023-34524-x |
Ejemplares similares
-
Investigation of fatty acid metabolism-related genes in breast cancer: Implications for Immunotherapy and clinical significance
por: Tang, Liyang, et al.
Publicado: (2023) -
Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023) -
Mechanisms of proton pump inhibitor‐induced hypomagnesemia
por: Gommers, Lisanne M. M., et al.
Publicado: (2022) -
Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008) -
Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)